Nospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University. We aim to deliver novel and effective therapeutics as quickly as possible to make a lasting difference in the lives of millions of patients and their caring families.
| Website | https://www.nospharma.ca |
| Employees | 3 (3 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Rare Genetic Disorders, Pediatric Drug Development, Rare Disease Research, Developmental Therapies, Gene Therapy Research, Clinical Stage Drug Development, Pharmaceutical Research, Neurological Research, Drug Development, Therapeutics, Biotechnology, Rare Diseases |
Looking for a particular Nospharma employee's phone or email?
Nospharma Questions
Anmol Nagpal is the CEO and Co-Founder of Nospharma.
3 people are employed at Nospharma.
Nospharma is based in Montreal, Quebec.
Top Nospharma Employees
-
Anmol Nagpal
CEO and Co-Founder at Nospharma
Montreal, QC, CA2 -
David Baker
Head of Corporate Development at Nospharma
Philadelphia, PA, US15+ -
Derek Bowie
Government and Public Affairs Committee at Nospharma
Montreal, QC, CA5
Related Companies
